From our Swiss qualitative study with pharma leaders: decision-making has narrowed in horizon, slowing cross-functional execution and increasing rework. Layer in frequent reorganisations, budget constraints, and digitalisation (incl. AI), and a 2026 performance risk comes into focus: employee engagement drops before results do.

Join our free 40-minute session designed for HR leaders, HRBPs, L&D / People & Org Development, and department heads who want a clear way to check if these patterns are present in their organisation—and what to do next.

Can’t attend live? Register to receive the recording and the insights deck.

This isn’t a sales pitch. We ran this study for ourselves—pharma is one of Bevel’s core practice areas—and the findings were strong enough to share openly. Come hear what we found, pressure-test it against your reality, and help refine the 2026 forecast with industry peers who understand how team engagement directly drives business performance.

Not in pharma? You’re still welcome—the patterns and tools apply across industries.